Literature DB >> 24426108

Optimization of Biotransformation of l-Tyrosine to l-DOPA by Yarrowia lipolytica-NCIM 3472 Using Response Surface Methodology.

Swati T Gurme1, Shripad N Surwase2, Sushama A Patil1, Shekhar B Jadhav3, Jyoti P Jadhav1.   

Abstract

l-DOPA (3,4-dihydroxyphenyl-l-alanine) is the most widely used drug for treatment of Parkinson's disease. In this study Yarrowia lipolytica-NCIM 3472 biomass was used for transformation of l-tyrosine to l-DOPA. The process parameters were optimized using response surface methodology (RSM). The optimum values of the tested variables for the production of l-DOPA were: pH 7.31, temperature 42.9 °C, 2.31 g l(-1) cell mass and 1.488 g l(-1)l-tyrosine. The highest yield obtained with these optimum parameters along with recycling of the cells was 4.091 g l(-1). This optimization of process parameters using RSM resulted in 4.609-fold increase in the l-DOPA production. The statistical analysis showed that the model was significant. Also coefficient of determination (R(2)) was 0.9758, indicating a good agreement between the experimental and predicted values of l-DOPA production. The highest tyrosinase activity observed was 7,028 U mg(-1) tyrosine. l-DOPA production was confirmed by HPTLC and HPLC analysis. Thus, RSM approach effectively enhanced the potential of Y. lipolytica-NCIM 3472 as an alternative source to produce l-DOPA.

Entities:  

Keywords:  Box–Behnken design; RSM; Tyrosinase; Yarrowia lipolytica; l-DOPA; l-Tyrosine

Year:  2013        PMID: 24426108      PMCID: PMC3626946          DOI: 10.1007/s12088-012-0346-z

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  6 in total

1.  Bioconversion of L-tyrosine to L-DOPA by a novel bacterium Bacillus sp. JPJ.

Authors:  Shripad N Surwase; Jyoti P Jadhav
Journal:  Amino Acids       Date:  2010-10-21       Impact factor: 3.520

2.  Innovative effect of illite on improved microbiological conversion of L-tyrosine to 3,4 dihydroxy phenyl L-alanine (L-DOPA) by Aspergillus oryzae ME2 under acidic reaction conditions.

Authors:  Ali Sikander
Journal:  Curr Microbiol       Date:  2006-10-12       Impact factor: 2.188

3.  Efficient microbial conversion of L-tyrosine to L-DOPA by Brevundimonas sp. SGJ.

Authors:  Shripad N Surwase; Sushama A Patil; Onkar A Apine; Jyoti P Jadhav
Journal:  Appl Biochem Biotechnol       Date:  2012-02-10       Impact factor: 2.926

4.  Production of L-DOPA from cell suspension culture of Mucuna pruriens f. pruriens.

Authors:  S Chattopadhyay; S K Datta; S B Mahato
Journal:  Plant Cell Rep       Date:  1994-06       Impact factor: 4.570

5.  Transformation of L-tyrosine to L-dopa by a novel fungus, Acremonium rutilum, under submerged fermentation.

Authors:  R Krishnaveni; Vandana Rathod; M S Thakur; Y F Neelgund
Journal:  Curr Microbiol       Date:  2009-01-03       Impact factor: 2.188

6.  High performance microbiological transformation of L-tyrosine to L-dopa by Yarrowia lipolytica NRRL-143.

Authors:  Sikander Ali; Jeffry L Shultz
Journal:  BMC Biotechnol       Date:  2007-08-16       Impact factor: 2.563

  6 in total
  2 in total

1.  Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routes.

Authors:  Matthew J Haney; Yuling Zhao; James Fay; Hwang Duhyeong; Mengzhe Wang; Hui Wang; Zibo Li; Yueh Z Lee; Mohan K Karuppan; Nazira El-Hage; Alexander V Kabanov; Elena V Batrakova
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

2.  GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice.

Authors:  Yuling Zhao; Matthew J Haney; Yeon S Jin; Olga Uvarov; Natasha Vinod; Yueh Z Lee; Benjamin Langworthy; Jason P Fine; Myosotys Rodriguez; Nazira El-Hage; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2019-10-31       Impact factor: 9.776

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.